Dachaigh › Leukemia myeloid geur
Sgrùdaidhean clionaigeach Leukemia myeloid geur a’ fastadh anns na SA
Tha 276 sgrùdaidhean airson Leukemia myeloid geur a’ fastadh phàirtichean aig làraichean air feadh nan Stàitean Aonaichte.
Bailtean leis na sgrùdaidhean as motha
- Houston, TX85 sgrùdaidhean
- New York City, NY51 sgrùdaidhean
- Boston, MA44 sgrùdaidhean
- Seattle, WA41 sgrùdaidhean
- Baldwin Park, CA40 sgrùdaidhean
- Columbus, OH35 sgrùdaidhean
- Philadelphia, PA34 sgrùdaidhean
- Durham, NC33 sgrùdaidhean
- Atlanta, GA31 sgrùdaidhean
- Tampa, FL29 sgrùdaidhean
- Chicago, IL26 sgrùdaidhean
- Portland, OR25 sgrùdaidhean
- Washington, DC24 sgrùdaidhean
- Los Angeles, CA24 sgrùdaidhean
- Miami, FL24 sgrùdaidhean
- St. Louis, MO22 sgrùdaidhean
- Nashville, TN21 sgrùdaidhean
- Dallas, TX21 sgrùdaidhean
- Birmingham, AL21 sgrùdaidhean
- Queens, NY21 sgrùdaidhean
- Minneapolis, MN20 sgrùdaidhean
- Cincinnati, OH20 sgrùdaidhean
- Edison, NJ20 sgrùdaidhean
- Cleveland, OH20 sgrùdaidhean
- Mountain View, CA19 sgrùdaidhean
- Buffalo, NY19 sgrùdaidhean
- Baltimore, MD19 sgrùdaidhean
- Greenburgh, NY18 sgrùdaidhean
- Pittsburgh, PA18 sgrùdaidhean
- Winston-Salem, NC18 sgrùdaidhean
- Salt Lake City, UT17 sgrùdaidhean
- New Haven, CT17 sgrùdaidhean
- Ann Arbor, MI17 sgrùdaidhean
- Milwaukee, WI17 sgrùdaidhean
- Madison, WI16 sgrùdaidhean
- Aurora, CO16 sgrùdaidhean
- Cedar Rapids, IA16 sgrùdaidhean
- Charlottesville, VA16 sgrùdaidhean
- Charlotte, NC16 sgrùdaidhean
- Rochester, NY16 sgrùdaidhean
Le stàit
- Alabama21 sgrùdaidhean
- Arizona22 sgrùdaidhean
- Arkansas13 sgrùdaidhean
- California79 sgrùdaidhean
- Colorado22 sgrùdaidhean
- Connecticut17 sgrùdaidhean
- Delaware7 sgrùdaidhean
- Florida55 sgrùdaidhean
- Georgia39 sgrùdaidhean
- Hawaii7 sgrùdaidhean
- Idaho9 sgrùdaidhean
- Illinois31 sgrùdaidhean
- Indiana14 sgrùdaidhean
- Iowa17 sgrùdaidhean
- Kansas21 sgrùdaidhean
- Kentucky14 sgrùdaidhean
- Louisiana13 sgrùdaidhean
- Maine9 sgrùdaidhean
- Maryland31 sgrùdaidhean
- Massachusetts45 sgrùdaidhean
- Michigan24 sgrùdaidhean
- Minnesota27 sgrùdaidhean
- Mississippi8 sgrùdaidhean
- Missouri23 sgrùdaidhean
- Montana7 sgrùdaidhean
- Nebraska10 sgrùdaidhean
- Nevada9 sgrùdaidhean
- New Hampshire9 sgrùdaidhean
- New Jersey32 sgrùdaidhean
- New Mexico9 sgrùdaidhean
- New York71 sgrùdaidhean
- North Carolina43 sgrùdaidhean
- North Dakota4 sgrùdaidhean
- Ohio57 sgrùdaidhean
- Oklahoma14 sgrùdaidhean
- Oregon27 sgrùdaidhean
- Pennsylvania45 sgrùdaidhean
- Rhode Island11 sgrùdadh
- Sgìre Cholumbia10 sgrùdaidhean
- South Carolina16 sgrùdaidhean
- South Dakota6 sgrùdaidhean
- Tennessee31 sgrùdaidhean
- Texas94 sgrùdaidhean
- Utah17 sgrùdaidhean
- Vermont7 sgrùdaidhean
- Virginia24 sgrùdaidhean
- Washington42 sgrùdaidhean
- West Virginia6 sgrùdaidhean
- Wisconsin25 sgrùdaidhean
Sgrùdaidhean air an ùrachadh o chionn ghoirid
Teacsa sgrùdaidh oifigeil (Beurla)
Comparing Different Treatment Lengths for Venetoclax in Older People With Newly Diagnosed Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)
A’ fastadhÌre 2
Aoisean 60 agus nas sine · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT07437950MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT05564390Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Bone Marrow or Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies
A’ fastadhÌre 1 tràth
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT06398457A Study to Assess Adverse Events and How Intravenous (IV) Pivekimab Sunirine Moves Through the Body in Pediatric Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML)
A’ fastadhÌre 1
6 Months – 17 Years · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT07306832Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies
A’ fastadhÌre 1
Aoisean 18 gu 120 · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT06904066Ivosidenib as Post-HSCT Maintenance for AML
A’ fastadhÌre 2
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT06707493Venetoclax, Cladribine, Low Dose Cytarabine, and Azacitidine in Treating Patients With Previously Untreated Acute Myeloid Leukemia
A’ fastadhÌre 2
Aoisean 50 agus nas sine · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT03586609A Study to Find the Highest Dose of Cedazuridine and Decitabine Combination With Filgrastim as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With High-Risk Acute Myeloid Leukemia
A’ fastadhÌre 1
Suas gu aois 21 · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT07012044Ruxolitinib With Azacitidine Maintenance for the Treatment of Patients With Acute Myeloid Leukemia Undergoing Reduced Intensity Allogeneic Stem Cell Transplantation
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT07548983Phase 1 Open-label Study of AMX-883 Alone in Participants With AML and High-risk MDS and in Combination in Participants With AML
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT07723703Olutasidenib With Azacitidine Followed by Olutasidenib Maintenance for the Treatment of IDH1-mutated Acute Myeloid Leukemia in Patients With Prior Treatment With Venetoclax Plus a Hypomethylating Agent
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT07304011A Study to Assess Adverse Events and Change in Disease Activity When Intravenous (IV) Pivekimab Sunirine is Given in Combination With Oral Venetoclax and IV or Subcutaneous Azacitidine in Adult Participants With Acute Myeloid Leukemia (AML)
A’ fastadhÌre 2/3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT07581002Assessment of Geriatric Evaluations Impact on New AML Guidance
A’ fastadhSgrùdadh amharc
Aoisean 50 agus nas sine · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT05909501Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
Aoisean 40 gu 75 · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT05334069Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
A’ fastadhSgrùdadh amharc
Aoisean 0 gu 38 · Gach gnè · Air ùrachadh 1 Dàmh 2026 · NCT06131801Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 1 Dàmh 2026 · NCT06484062A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies
A’ fastadhÌre 1
Aoisean 12 gu 78 · Gach gnè · Air ùrachadh 29 Sult 2026 · NCT03802695A Phase 1 Study of AOH1996 in Patients With Relapsed/Refractory Acute Myeloid Leukemia
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 29 Sult 2026 · NCT06763341Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
A’ fastadhÌre 2
Aoisean 18 gu 59 · Gach gnè · Air ùrachadh 28 Sult 2026 · NCT05554393Liposome-encapsulated Daunorubicin-Cytarabine and Venetoclax in Treating Participants With Relapsed, Refractory or Untreated Acute Myeloid Leukemia
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT03629171A Phase 1B/2A Trial of NADUNOLIMAB in Combination With Azacitidine (With/Without Venetoclax) in Patients With Myelodysplastic Syndrome (MDS) and Acute Myelogenous Leukemia (AML)
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT06548230Study of Revumenib in Combination With Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML) With a NPM1 Mutation
A’ fastadhÌre 3
Aoisean 12 agus nas sine · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT07211958A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT06852222Quizartinib, Decitabine, and Venetoclax in Treating Participants With Untreated or Relapsed Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 24 Sult 2026 · NCT03661307Ruxolitinib in Combination With Venetoclax With and Without Azacitidine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 24 Sult 2026 · NCT03874052Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.